Carbohydrate-mediated tumor targeting
US-9624255-B2 · Apr 18, 2017 · US
US10046068B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10046068-B2 |
| Application number | US-201414776578-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 14, 2014 |
| Priority date | Mar 15, 2013 |
| Publication date | Aug 14, 2018 |
| Grant date | Aug 14, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This invention relates to compounds comprising a saccharide conjugated to an imaging agent or a reporter group, compositions comprising them and methods of using them. Specifically BLM-disaccharide and BLM-monosaccharide conjugates containing different linker groups and an imaging agent or a reporter group are provided for the targeting and imaging of tumors.
Opening claim text (preview).
What is claimed is: 1. A compound of formula (I): [A-R 6 n R 7 —R 8 (I) or a pharmaceutically acceptable salt thereof, wherein A is: R 1 is selected from the group consisting of H, OH, SH, NH 2 , OR 4 , OC(O)R 4 , OC(O)NHR 4 , OC(O)NR 4 R 5 , OC(S)NHR 4 , OC(S)NR 4 R 5 , SC(O)NHR 4 , SC(O)NR 4 R 5 , NHC(O)NHR 4 , NHC(O)NR 4 R 5 , NHC(S)NHR 4 , NHC(S)NR 4 R 5 , NHC(N)NHR 4 , NHC(N)NR 4 R 5 , OCH 2 C(O)NHR 4 , OCH 2 C(O)NR 4 R 5 , OCH 2 C(S)NHR 4 , OCH 2 C(S)NR 4 R 5 , SCH 2 C(O)NHR 4 , SCH 2 C(O)NR 4 R 5 , NHCH 2 C(O)NHR 4 , NHCH 2 C(O)NR 4 R 5 , NHCH 2 C(S)NHR 4 and NHCH 2 C(S)NR 4 R 5 ; each R 4 is selected from the group consisting of H, C 1 -C 6 alkyl, C 2 -C 6 alkenyl and C 2 -C 6 alkynyl; each R 5 is selected from the group consisting of C 1 -C 6 alkyl, C 2 -C 6 alkenyl and C 2 -C 6 alkynyl; R 2 is selected from the group consisting of H, OH, SH, NH 2 , OR 4 , OC(O)R 4 , OC(O)NHR 4 , OC(O)NR 4 R 5 , OC(S)NHR 4 , OC(S)NR 4 R 5 , SC(O)NHR 4 , SC(O)NR 4 R 5 , NHC(O)NHR 4 , NHC(O)NR 4 R 5 , NHC(S)NHR 4 , NHC(S)NR 4 R 5 , NHC(N)NHR 4 , NHC(N)NR 4 R 5 , OCH 2 C(O)NHR 4 , OCH 2 C(O)NR 4 R 5 , OCH 2 C(S)NHR 4 , OCH 2 C(S)NR 4 R 5 , SCH 2 C(O)NHR 4 , SCH 2 C(O)NR 4 R 5 , NHCH 2 C(O)NHR 4 , NHCH 2 C(O)NR 4 R 5 , NHCH 2 C(S)NHR 4 and NHCH 2 C(S)NR 4 R 5 ; R 3 is selected from the group consisting of H, OH, SH, NH 2 , OR 4 , OC(O)R 4 , OC(O)NHR 4 , OC(O)NR 4 R 5 , OC(S)NHR 4 , OC(S)NR 4 R 5 , SC(O)NHR 4 , SC(O)NR 4 R 5 , NHC(O)NHR 4 , NHC(O)NR 4 R 5 , NHC(S)NHR 4 , NHC(S)NR 4 R 5 , NHC(N)NHR 4 , NHC(N)NR 4 R 5 , OCH 2 C(O)NHR 4 , OCH 2 C(O)NR 4 R 5 , OCH 2 C(S)NHR 4 , OCH 2 C(S)NR 4 R 5 , SCH 2 C(O)NHR 4 , SCH 2 C(O)NR 4 R 5 , NHCH 2 C(O)NHR 4 , NHCH 2 C(O)NR 4 R 5 , NHCH 2 C(S)NHR 4 and NHCH 2 C(S)NR 4 R 5 ; R′ is selected from the group consisting of H, OH and NHR 4 ; R 6 is a first linker; n is an integer selected from 1 to 3; R 7 is absent or a second linker, provided that when n is 1, R 7 is absent; and R 8 is Cy5**. 2. The compound according to claim 1 , wherein A is selected from the group consisting of: 3. The compound according to claim 1 , wherein the first linker is X-(L 1 -Y) m -L 2 -Z, wherein X is CH 2 or O; L 1 is C 2 -C 6 alkyl; Y is O, S, or NR y , wherein R y is hydrogen or C 1 -C 6 alkyl; m is an integer selected from 1 to 10; L 2 is C 1 -C 20 alkyl, C 2 -C 20 alkenyl, C 2 -C 20 alkynyl, aryl, heteroaryl, heterocyclyl, C 3 -C 5 cycloalkyl; and Z is absent, O, NR x , S, C(O), S(O), S(O) 2 , OC(O), N(R x )C(O), N(R x )S(O), N(R x )S(O) 2 , C(O)O, C(O)N(R x ), S(O)N(R x ), S(O) 2 N(R x ), OC(O)O, OC(O)N(R x ), N(R x )C(O)O, N(R x )C(O)N(R x ), or N(R x )S(O) 2 N(R x ), wherein each R x is independently hydrogen or C 1 -C 6 alkyl. 4. The compound of claim 3 , wherein the first linker is O—(CH 2 CH 2 —O) m —CH 2 CH 2 —Z, wherein Z is O, N(H), or S and m is an integer selected from 1 to 20 or the first linker is O—(CH 2 CH 2 —O) m —CH 2 CH 2 —Z, wherein Z is C(O) or S(O) 2 and m is an integer selected from 1 to 20. 5. The compound according to claim 1 , wherein the second linker is (B-L 3 ) p -D-E-L 4 -F, wherein B is bond, O, NR x , S, C(O), S(O), S(O) 2 , OC(O), N(R x )C(O), N(R x )S(O), N(R x )S(O) 2 , C(O)O, C(O)N(R x ), S(O)N(R x ), S(O) 2 N(R x ), OC(O)O, OC(O)N(R x ), N(R x )C(O)O, N(R x )C(O)N(R x ), or N(R x )S(O) 2 N(R x ); L 3 is C 2 -C 6 alkyl; p is 2 or 3; D is CH when p is 2 and D is C when p is 3; E is a bond, O, NR x , S, C(O), S(O), S(O) 2 , OC(O), N(R x )C(O), N(R x )S(O), N(R x )S(O) 2 , C(O)O, C(O)N(R x ), S(O)N(R x ), S(O) 2 N(R x ), OC(O)O, OC(O)N(R x ), N(R x )C(O)O, N(R x )C(O)N(R x ), or N(R x )S(O) 2 N(R x ); L 4 is C 2 -C 6 alkyl; and F is a bond, O, NR x , S, C(O), S(O), S(O) 2 , OC(O), N(R x )C(O), N(R x )S(O), N(R x )S(O) 2 , C(O)O, C(O)N(R x ), S(O)N(R x ), S(O) 2 N(R x ), OC(O)O, OC(O)N(R X ), N(R X )C(O)O, N(R x )C(O)N(R x ), or N(R x )S(O) 2 N(R x ), wherein each R x is independently hydrogen or C 1 -C 6 alkyl. 6. The compound according to claim 1 , wherein R 1 is selected from the group consisting of H, OH, OR 4 , OC(O)R 4 , NHC(N)NHR 4 , NHC(N)NR 4 R 5 , OCONHR 4 , and OCONR 4 R 5 . 7. The compound according to claim 1 , wherein R 2 is selected from the group consisting of H, OH, OR 4 , OC(O)R 4 , NHC(N)NHR 4 , NHC(N)NR 4 R 5 , OCONHR 4 , OCONR 4 R 5 , OCSNHR 4 , NHCONHR 4 , OCH 2 CONHR 4 , and OCH 2 CONR 4 R 5 . 8. The compound according to claim 1 , wherein R 3 is selected from the group consisting of OH, OR 4 , OC(O)R 4 , NHC(N)NHR 4 , NHC(N)NR 4 R 5 , and OCONHR 4 . 9. The compound according to claim 1 , wherein R′ is H or OH. 10. The compound according to claim 1 , wherein each R 4 is selected from the group consisting of H, methyl and ethyl. 11. The compound according to claim 1 , wherein each R 5 is selected from the group consisting of methyl, ethyl, and isobutyl. 12. A compound selected from the group consisting of:
Microbubbles, hollow microspheres, free gas bubbles, gas microspheres · CPC title
Heterocyclic compounds (A61K47/558 takes precedence) · CPC title
conjugates with a carrier being an organic compounds · CPC title
General or multifunctional contrast agents, e.g. chelated agents · CPC title
Small organic molecules (oligomers, polymers, dendrimers A61K49/0054) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.